FDA Inspection 971695 — Dr. Paul Lohmann GmbH KG
The FDA completed an inspection of Dr. Paul Lohmann GmbH KG on Apr 14, 2016 in Luneburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Luneburg (Germany)